Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 42Leukemia 39Myelodysplastic Syndromes 29Congenital Abnormalities 12Lymphoma, Non-Hodgkin 9Leukemia, Myelomonocytic, Acute 8Leukemia, Monocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Leukemia, Biphenotypic, Acute 8Recurrence 7Lymphoma 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Hematologic Neoplasms 7Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Leukemia, Promyelocytic, Acute 4Leukemia, Myeloid, Accelerated Phase 4Blast Crisis 4Anemia, Refractory, with Excess of Blasts 4Neoplasms 3Multiple Myeloma 3Lymphoma, B-Cell 3Leukemia, Myelomonocytic, Juvenile 3Graft vs Host Disease 3Burkitt Lymphoma 3

Interventions

fludarabine phosphate 3fludarabine 2Whole-Body Irradiation 2Thiotepa 2Melphalan 2Cyclosporins 2Cyclosporine 2Antilymphocyte Serum 2Alemtuzumab 2plerixafor 1Voriconazole 1Tacrolimus 1Photopheresis 1Phlebotomy 1Mycophenolic Acid 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1Clofarabine 1Busulfan 1Blood Specimen Collection 1B-Cell Activating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Immunologic Deficiency Syndromes × Clofarabine × Clear all
NCT03609814 2021-10-04

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

University of California, San Francisco

Completed
30 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡